The Healthcare Internet of Things: A Network of Opportunities for All (2016)
This report casts a candid eye over the latest developments and plots a course for pharmaceutical companies wanting to maximise long-term commercial advantage. Based on in-depth discussions with 10 senior industry leaders at the forefront of technology.
Actelion reported Monday that a late-stage study of Opsumit (macitentan) in patients with pulmonary arterial hypertension (PAH) due to Eisenmenger syndrome failed to meet its primary objective. The... Read More >>